Lau­ra Shawver hits the ground run­ning, scout­ing new in­vestors for tiny Syn­thorx

Syn­thorx doesn’t make the news a lot. But when it does, it makes sure peo­ple pay at­ten­tion.

The syn­thet­ic bi­ol­o­gy start­up came out with two big an­nounce­ments this week: Lau­ra Shawver is tak­ing its helm as CEO, pres­i­dent and di­rec­tor; sci­en­tif­ic founder Floyd Romes­berg has pub­lished a pa­per in Na­ture dis­cussing how a se­mi-syn­thet­ic or­gan­ism can trans­late DNA with two ad­di­tion­al bases (X and Y) in­to nov­el pro­teins.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA